Search | TVST | ARVO Journals

Showing 1 – 20 of 65

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

Retina June 2024

Perimacular Atrophy Following Voretigene Neparvovec-Rzyl Treatment in the Setting of Previous Contralateral Eye Treatment With a Different Viral Vector

PDF

Cristy A. Ku; Austin D. Igelman; Samuel J. Huang; Steven T. Bailey; Andreas K. Lauer; Jacque L. Duncan; Richard G. Weleber; Paul Yang; Mark E. Pennesi
TAGS: atrophy, chorioretinal atrophy, eye, genes, viral vector, voretigene neparvovec, visual fields
Trans. Vis. Sci. Tech.. 2024; 13(6):11. https://doi.org/10.1167/tvst.13.6.11

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2024

Phenotypic Spectrum of Retinal Degeneration in X-Linked PRPS1 -Related Retinopathy

Ogul Uner; Radwa Elsharawi; Margaret Reynolds; Giacomo Bacci; Sara Bargiacchi; Fred Chen; Nieraj Jain; Rachael C Heath Jeffery; Mariana Matioli de Palma; Juliana M F Sallum; Mariam Torres Soto; Kaylie D Webb-Jones; Paul Yang; Mark E Pennesi; Lesley Everett

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):1702.

ARVO Annual Meeting Abstract June 2024

Six-year results of a Phase I/IIa gene therapy trial in patients with Usher Syndrome Type-1B (USH1B)

Maria Parker; Paul Yang; Dongseok Choi; Saddek Mohand-Said; Shobana Aravind; Ambar Faridi; Elvira Chegarnov; Charles Butler; Pierre-Olivier Barale; Andreas K Lauer; Tim Stout; David Wilson; Richard Weleber; Mark E Pennesi; Jose Alain Sahel; Isabelle S Audo

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):5327.

ARVO Annual Meeting Abstract June 2024

Establishing a gene editing strategy for BBS7 using human retinal organoids

Kathleen R Chirco; Jana M Giaquinto; Molly Marra; Paul Yang; Mark E Pennesi; Martha Neuringer

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):1555.

ARVO Annual Meeting Abstract June 2024

Developing an in vitro human USH1B model to study retinal disease features

Jana M Giaquinto; Molly Marra; Paul Yang; Mark E Pennesi; Kathleen R Chirco

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):1574.

ARVO Annual Meeting Abstract June 2024

Wide-Field Swept-source structural OCT and OCT Angiography in Inherited Retinal Dystrophies

Xiao Zhou; Nida Wongchaisuwat; Guangru Ben Liang; Tristan T Hormel; Lesley Everett; Paul Yang; Mark E Pennesi; Yali Jia

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):5495.

ARVO Annual Meeting Abstract June 2024

Subretinal gene therapy AGTC-501 for X-linked retinitis pigmentosa in the Phase 1/2 Horizon study: Post-hoc analysis of microperimetry results in the high dose groups

David G Birch; Andreas K Lauer; Paul Yang; Robert Sisk; Rajiv Anand; Darin Curtiss; Amy Christenson; Nadia K Waheed

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2133.

ARVO Annual Meeting Abstract June 2024

LAMA1 associated retinopathy: a case series

Andrew Lamborn; Emma Bedoukian; Arif O. Khan; Fernanda Belga Ottoni Porto; Molly Marra; Paul Yang; Mark E Pennesi; Lesley Everett

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):3463.

ARVO Annual Meeting Abstract June 2024

Generating Models of PRPH2 -associated retinal dystrophy

Renee Christine Ryals; Nadia Moore; Lauren Renner; Jana M Giaquinto; Molly Marra; Hannah Woolard; Paul Yang; Mark E Pennesi; Samuel Peterson; Besty Ferguson; Martha Neuringer; Kathleen R Chirco

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):817.

ARVO Annual Meeting Abstract June 2024

OCU400 Nuclear Hormone Receptor-Based Gene Modifier Therapy: Safety and Efficacy from Phase 1/2 Clinical Trial for Retinitis Pigmentosa Associated with NR2E3 and RHO Mutations

Byron L Lam; Arun K Upadhyay; Shankar Musunuri; Murthy Chavali; Sahar Matloob; Nalin Mehta; David G Birch; Paul Yang; Benjamin Bakall; Nieraj Jain; Jose S. Pulido; Borooah Shyamanga

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):406.

ARVO Annual Meeting Abstract June 2024

Inhibition of Inosine Monophosphate Dehydrogenase (IMPDH) Mitigates Guanine Nucleotide Dysregulation in rd10 Mice

Paul Yang; Alexander Hurt; Luke Fraley; Catherine W Morgans; Mark E Pennesi; Robert Duvoisin

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):1465.

ARVO Annual Meeting Abstract June 2024

Using Machine Learning to Assess the Pathogenicity of Small In-frame Indels in Inherited Retinal Disease

David Eldon Rauch; Meng Wang; Hafiz Muhammad Jafar Hussain; Daniel Christopher Brock; Yumei Li; Molly Marra; Mark E Pennesi; Paul Yang; Lesley Everett; Irma Lopez; Edward Ryan Collantes; Joanne Bolinao; Rui Chen

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):4688.

ARVO Annual Meeting Abstract June 2024

Comparative Analysis of In-Silico Tools in Identifying Pathogenic Variants in Dominant Inherited Retinal Diseases

Daniel Christopher Brock; Meng Wang; Hafiz Muhammad Jafar Hussain; David Rauch; Molly Marra; Mark E Pennesi; Paul Yang; Lesley Everett; Yumei Li; Rui Chen

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):4657.

ARVO Annual Meeting Abstract June 2024

The Effect of Long-term Systemic versus Local Immunosuppression on Electroretinography in Birdshot Chorioretinopathy

Christopher R Rosenberg; Elizabeth White; Aseel Alsamarraie; Sandip Suresh; Wayne Tschetter; Rene Choi; Richard Weleber; James Rosenbaum; Justine R Smith; Phoebe Lin; Mark E Pennesi; Eric B Suhler; Paul Yang

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):5874.

ARVO Annual Meeting Abstract June 2024

Using cytokine profiling to characterize the immune response associated with AAV subretinal administration

Rene Stephen Reynaga; Jonathan Stoddard; Lauren Renner; Hannah Woolard; Andreas K Lauer; Sanford L Boye; Shannon Elizabeth Boye; Steven Grey; Alison Weiss; Will Liguore; Trevor J Mcgill; Paul Yang; Renee Christine Ryals; Martha Neuringer

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):6088.

ARVO Annual Meeting Abstract June 2024

Characterization of Flavimaculatus-Like Phenotype in PRPH2 associated Inherited Retinal Disease

Shaden Yassin; Naomi Wagner; Paripoorna Sharma; Evan Walker; Fritz Gerald Paguiligan Kalaw; Thiago DeOliveira; Katherine Andersen; Molly Marra; Lesley Everett; Paul Yang; Mark E Pennesi; Shyamanga Borooah

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):OD74.

ARVO Annual Meeting Abstract June 2023

Challenges of common variants for risk assessment and genetic counseling of inherited retinal diseases

Molly Marra; Emma Bedoukain; Kaitlin O’Connell; Emily Place; Michelle Alabek; Erin O'Neil; Tomas S Aleman; Drew Scoles; Jason Comander; Rachel M Huckfeldt; Boris Rosin; Jose Sahel; Lesley Everett; Paul Yang; Mark E Pennesi

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):400.

ARVO Annual Meeting Abstract June 2023

Six-month safety and efficacy of ATSN-101 in patients with Leber congenital amaurosis caused by biallelic mutations in GUCY2D (LCA1)

Christine Nichols Kay; Paul Yang; Artur V Cideciyan; Allen Ho; Andreas K Lauer; Shannon E Boye; Sanford L Boye; Alejandro J Roman; Vivian Wu; Alexandra V Garafalo; Alexander Sumaroka; Laura P Pardon; Dan Yoon; Kenji P Fujita; Samuel Jacobson

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):1914.

ARVO Annual Meeting Abstract June 2023

Development of a full-field two-color dark-adapted perimetry protocol using an unmodified perimeter

Samuel J Huang; Alessia Amato; Ryan Schmidt; Wayne Tschetter; Austin David Igelman; Lesley Everett; Paul Yang; Mark E Pennesi

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):3341.

ARVO Annual Meeting Abstract June 2023

Electrophysiological characterization of active versus inactive birdshot retinochoroidopathy

Christopher Ryan Rosenberg; Elizabeth White; Aseel Alsamarraie; Sandip Suresh; Wayne Tschetter; Rene Choi; Richard Weleber; Phoebe Lin; Mark E Pennesi; Eric Suhler; Paul Yang

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):5208.

1 2 3 4

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Filters

Specify Date Range

Perimacular Atrophy Following Voretigene Neparvovec-Rzyl Treatment in the Setting of Previous Contralateral Eye Treatment With a Different Viral Vector

Phenotypic Spectrum of Retinal Degeneration in X-Linked PRPS1 -Related Retinopathy

Six-year results of a Phase I/IIa gene therapy trial in patients with Usher Syndrome Type-1B (USH1B)

Establishing a gene editing strategy for BBS7 using human retinal organoids

Developing an in vitro human USH1B model to study retinal disease features

Wide-Field Swept-source structural OCT and OCT Angiography in Inherited Retinal Dystrophies

Subretinal gene therapy AGTC-501 for X-linked retinitis pigmentosa in the Phase 1/2 Horizon study: Post-hoc analysis of microperimetry results in the high dose groups

LAMA1 associated retinopathy: a case series

Generating Models of PRPH2 -associated retinal dystrophy

OCU400 Nuclear Hormone Receptor-Based Gene Modifier Therapy: Safety and Efficacy from Phase 1/2 Clinical Trial for Retinitis Pigmentosa Associated with NR2E3 and RHO Mutations

Inhibition of Inosine Monophosphate Dehydrogenase (IMPDH) Mitigates Guanine Nucleotide Dysregulation in rd10 Mice

Using Machine Learning to Assess the Pathogenicity of Small In-frame Indels in Inherited Retinal Disease

Comparative Analysis of In-Silico Tools in Identifying Pathogenic Variants in Dominant Inherited Retinal Diseases

The Effect of Long-term Systemic versus Local Immunosuppression on Electroretinography in Birdshot Chorioretinopathy

Using cytokine profiling to characterize the immune response associated with AAV subretinal administration

Characterization of Flavimaculatus-Like Phenotype in PRPH2 associated Inherited Retinal Disease

Challenges of common variants for risk assessment and genetic counseling of inherited retinal diseases

Six-month safety and efficacy of ATSN-101 in patients with Leber congenital amaurosis caused by biallelic mutations in GUCY2D (LCA1)

Development of a full-field two-color dark-adapted perimetry protocol using an unmodified perimeter

Electrophysiological characterization of active versus inactive birdshot retinochoroidopathy

To View More...

You must be signed into an individual account to use this feature.